Health Care: Drugs

Halozyme Therapeutics Inc (HALO: NASDAQ)

$9.88 n/a | n/a%
09/17/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 54.80M 42.33M 56.09M 13.62M
Cost of Sales 3.90M 14.98K 257.83K 985.28K
Gross Operating Profit 50.90M 42.31M 55.83M 12.64M
Selling, General, and Administrative Expenses 32.35M 24.81M 18.10M 15.12M
Research & Development 96.64M 70.04M 57.56M 51.77M
Operating Income before D & A (EBITDA) -78.09M -52.55M -19.84M -54.26M
Depreciation & Amortization 2.34M 1.08M 1.10M 1.51M
Interest Income 229.23K 59.03K 63.53K 49.02K
Other Income - Net 0.00 14.42K 5.56K 966.97K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -80.20M -53.55M -20.87M -54.75M
Interest Expense 3.27M 0.00 0.00 0.00
Pre-Tax Income -83.48M -53.55M -20.87M -54.75M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -83.48M -53.55M -19.77M -53.24M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -83.48M -53.55M -19.77M -53.24M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -83.48M -53.55M -19.77M -53.24M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-83.48M -53.55M -19.77M -53.24M
Preferred Dividends
Net Income Available To Common -83.48M -53.55M -19.77M -53.24M
Basic EPS from Continuing Ops. -0.74 -0.48 -0.19 -0.56
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.74 -0.48 -0.19 -0.56
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.74 -0.48 -0.19 -0.56
Basic Normalized Net Income/Share -0.74 -0.48 -0.19 -0.56
EPS fr Continuing Ops. -0.74 -0.48 -0.19 -0.56
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.74 -0.48 -0.19 -0.56
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.74 -0.48 -0.19 -0.56
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.74 -0.48 -0.19 -0.56
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with HALO

Latest HALO Headlines from TheStreet

More Financial News for HALO

Press Releases for HALO

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter